Bartel is part of a growing number of GLP-1 users across the country undergoing “second-wave” transformations, newly inspired ...
I spoke with neuroscientists from an Incheon, Korea-based startup that's looking to minimize the symptoms of epilepsy or Parkinson's disease.
As interest in GLP-1 medication grows, scammers are tricking consumers with fake alternatives. Here's how to spot them.